First MRI-Safe CRT-D Devices Approved
Friday, February 5, 2016
Source: MedPage Today
The FDA approved the Amplia and Compia MRI Quad cardiac resynchronization therapy defibrillator (CRT-D) SureScan devices for heart failure patients, manufacturer Medtronic announced on Friday morning.
Both devices are the first CRT-Ds approved that will be safe with subsequent MRI scanning throughout the body. Cardiac resynchronization therapy had previously been contraindicated for MRI scanning due to a possible interaction between the devices.